{
    "nct_id": "NCT03724942",
    "title": "A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Safety of Extended Treatment With Brexpiprazole (OPC-34712) to Patients With Agitation Associated With Dementia of the Alzheimer's Type",
    "status": "COMPLETED",
    "last_update_time": "2024-05-09",
    "description_brief": "To evaluate the safety of brexpiprazole 1 mg or 2 mg after a 14 week treatment regimen for agitation associated with dementia of the Alzheimer's type patients who completed in a double-blind trial, and to investigate the efficacy of brexpiprazole.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "ROLLOVER BREX",
                    "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                },
                {
                    "id": "FG001",
                    "title": "ROLLOVER PLACEBO",
                    "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "102"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "62"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "73"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "44"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "29"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "18"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "20"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "14"
                                }
                            ]
                        },
                        {
                            "type": "Lack of Efficacy",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Physician Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Legal Representative",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "3"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "This trial was conducted in 164 participants in Japan.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "ROLLOVER BREX",
                    "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                },
                {
                    "id": "BG001",
                    "title": "ROLLOVER PLACEBO",
                    "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "102"
                        },
                        {
                            "groupId": "BG001",
                            "value": "62"
                        },
                        {
                            "groupId": "BG002",
                            "value": "164"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "8"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "96"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "60"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "156"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "79.0",
                                            "spread": "6.8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "80.2",
                                            "spread": "6.9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "79.5",
                                            "spread": "6.8"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "65"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "36"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "101"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "63"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race/Ethnicity, Customized",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "Asian",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "102"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "164"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Japan",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "102"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "164"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "The Frequency of Subjects With Treatment-Emergent Adverse Events (TEAEs)",
                    "description": "This trial enrolled subjects rolled over from Trial 331-102-00088, and the safety of brexpiprazole when administered for a maximum of 24 weeks (including the treatment period of Trial 331-102-00088) was evaluated.",
                    "populationDescription": "The safety analysis set comprised subjects who have received at least 1 dose of the IMP.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Percentage of percipitante",
                    "timeFrame": "From baseline to week 14",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "ROLLOVER BREX",
                            "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                        },
                        {
                            "id": "OG001",
                            "title": "ROLLOVER PLACEBO",
                            "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "102"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "62"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "90.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "90.3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Mean Change From Baseline in Cohen-Mansfield Agitation Inventory (CMAI) Score at 14 Weeks After Dosing",
                    "description": "The CMAI assessed the frequency of agitated behaviors in elderly persons, such as hitting, cursing, and restlessness. It consisted of 29 items all rated on a 1 to 7 scale with 1 being the \"best\" rating and 7 being the \"worst\" rating. The minimum possible CMAI total score was 29, and the maximum possible CMAI total score was 203. A decrease in score indicated improvement in symptoms.",
                    "populationDescription": "The efficacy analysis set will comprise subjects who have received at least 1 dose of the IMP and from whom CMAI total scores have been obtained at baseline and at least 1 time point after initiation of treatment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline and 14 weeks after dosing",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "ROLLOVER BREX",
                            "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                        },
                        {
                            "id": "OG001",
                            "title": "ROLLOVER PLACEBO",
                            "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "96"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "60"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.5",
                                            "spread": "9.9"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-6.4",
                                            "spread": "9.3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Mean Change From Baseline in Clinical Global Impression of Severity (CGI-S) Score at 14 Weeks After Dosing.",
                    "description": "The CGI-S was used to rate the severity of agitation. Scores were: 0 = not assessed; 1 = normal, not at all ill; 2 = borderline mentally ill; 3 = mildly ill; 4 = moderately ill; 5 = markedly ill; 6 = severely ill; and 7 = among the most extremely ill participants. A decrease in score indicated improvement in symptoms.",
                    "populationDescription": "The efficacy analysis set will comprise subjects who have received at least 1 dose of the IMP and from whom CMAI total scores have been obtained at baseline and at least 1 time point after initiation of treatment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline and 14 weeks after dosing.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "ROLLOVER BREX",
                            "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                        },
                        {
                            "id": "OG001",
                            "title": "ROLLOVER PLACEBO",
                            "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "96"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "60"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.2",
                                            "spread": "0.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.4",
                                            "spread": "1.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Global Impression of Improvement (CGI-I) Score at 14 Weeks After Dosing",
                    "description": "The CGI-I Scale was clinician-rated scale which assessed the total improvement of the patient's condition compared to that at baseline. Scores range from 0 to 7: 0 = Not assessed, 1= Very much improved, 2 = Much improved, 3= Minimally improved, 4= No change, 5= Minimally worse, 6= Much worse, 7= Very much worse. Higher scores indicate worse condition.",
                    "populationDescription": "The efficacy analysis set will comprise subjects who have received at least 1 dose of the IMP and from whom CMAI total scores have been obtained at baseline and at least 1 time point after initiation of treatment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "14 weeks after dosing.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "ROLLOVER BREX",
                            "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088"
                        },
                        {
                            "id": "OG001",
                            "title": "ROLLOVER PLACEBO",
                            "description": "Rollover subjects from the placebo group in Trial 331-102-00088"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "96"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "60"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.1",
                                            "spread": "1.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.7",
                                            "spread": "1.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "2",
            "timeFrame": "Adverse events were monitored from signing of the informed consent form through 35 days after last dose of study drug (Up to approximately Week 19)",
            "description": "Subjects who received at least one dose of IMP were included in the safety analysis.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "ROLLOVER BREX",
                    "description": "Rollover subjects from the brexpiprazole group in Trial 331-102-00088",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 102,
                    "seriousNumAffected": 7,
                    "seriousNumAtRisk": 102,
                    "otherNumAffected": 90,
                    "otherNumAtRisk": 102
                },
                {
                    "id": "EG001",
                    "title": "ROLLOVER PLACEBO",
                    "description": "Rollover subjects from the placebo group in Trial 331-102-00088",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 62,
                    "seriousNumAffected": 4,
                    "seriousNumAtRisk": 62,
                    "otherNumAffected": 55,
                    "otherNumAtRisk": 62
                }
            ],
            "seriousEvents": [
                {
                    "term": "Gait disturbance",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Pneumonia aspiration",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Femoral neck fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Femur fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Subdural haematoma",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Blood creatine phosphokinase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Muscle rigidity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Akathisia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Bradykinesia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Pneumothorax",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Dry eye",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 8,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Salivary hypersecretion",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 6,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Gait disturbance",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Oedema",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Pyrexia",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Peripheral swelling",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Hepatic function abnormal",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Conjunctivitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Herpes zoster",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Nasopharyngitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Tinea pedis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 12,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Femur fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Subcutaneous haematoma",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Contusion",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 8,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 5,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Wound",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Skin laceration",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Skin abrasion",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 11,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Blood albumin decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Blood creatine phosphokinase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Weight decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Weight increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Hepatic enzyme increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Hypokalaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Decreased appetite",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 6,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Arthralgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Muscle rigidity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 9,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Akathisia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Bradykinesia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 9,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Dyskinesia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Dystonia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Extrapyramidal disorder",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 6,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Parkinsonism",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Seizure",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Somnolence",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 13,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 7,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Tremor",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Sedation complication",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 7,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 9,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Insomnia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 12,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Restlessness",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Urinary incontinence",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Decubitus ulcer",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Dermatitis contact",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Dry skin",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Erythema",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Skin exfoliation",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 4,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 62
                        }
                    ]
                },
                {
                    "term": "Internal haemorrhage",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA version 25.0",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 102
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 3,
                            "numAtRisk": 62
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Director of Clinical Trials",
                "organization": "Otsuka Pharmaceutical Co., Ltd.",
                "email": "CL_OPCJ_RDA_Team@otsuka.jp",
                "phone": "+81363617366"
            }
        }
    },
    "target_category": "neuropsychiatric symptom improvement",
    "drug": [
        "Brexpiprazole (OPC-34712; brand name REXULTI) \u2014 a small\u2011molecule atypical antipsychotic / serotonin\u2013dopamine activity modulator (partial agonist at D2 and 5\u2011HT1A; antagonist at 5\u2011HT2A)."
    ],
    "placebo": [
        "Placebo (used as comparator in the double\u2011blind randomized brexpiprazole trials referenced in the description)."
    ],
    "explanation_target": [
        "Reason: The trial title and description explicitly state the population and intent: \"agitation associated with dementia of the Alzheimer's type\" and evaluation of brexpiprazole safety/efficacy in that indication. \ue200cite\ue202turn0search0\ue201",
        "Act: The investigational drug is brexpiprazole (OPC\u201134712), marketed as REXULTI; it is a small\u2011molecule atypical antipsychotic (serotonin\u2011dopamine activity modulator). \ue200cite\ue202turn1search7\ue202turn1search3\ue201",
        "Act (evidence of efficacy/safety focus): Randomized controlled trials and publications report brexpiprazole reduces agitation in Alzheimer dementia vs placebo and the program includes double\u2011blind placebo\u2011controlled studies; the described study is an open\u2011label extension evaluating longer\u2011term safety after those trials. \ue200cite\ue202turn0search7\ue202turn0search1\ue201",
        "Reflect: This intervention targets a neuropsychiatric symptom (agitation) through neurotransmitter modulation rather than targeting Alzheimer pathophysiology (amyloid/tau) or directly enhancing cognition. Therefore it fits the 'neuropsychiatric symptom improvement' category, not the disease\u2011targeted or cognitive\u2011enhancer categories. \ue200cite\ue202turn1search3\ue202turn0search2\ue201",
        "Additional supporting facts / citations: REXULTI (brexpiprazole) is indicated for treatment of agitation associated with dementia due to Alzheimer's disease (regulatory approval/labeling and sponsor publications describe this indication). \ue200cite\ue202turn1search6\ue202turn1search8\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial tests brexpiprazole (REXULTI) for agitation in Alzheimer's disease; brexpiprazole is an atypical antipsychotic/serotonin\u2013dopamine activity modulator (partial agonist at dopamine D2 and serotonin 5\u2011HT1A; antagonist at serotonin 5\u2011HT2A). This indicates the intervention acts by modulating neurotransmitter receptors to reduce neuropsychiatric symptoms rather than targeting core AD pathologies (amyloid, tau) or metabolic/vascular pathways. \ue200cite\ue202turn0search1\ue202turn0search3\ue201",
        "Act: Extracted details \u2014 drug: brexpiprazole (OPC\u201134712; REXULTI). Mechanism: partial agonist at D2 and 5\u2011HT1A and antagonist at 5\u2011HT2A (neurotransmitter receptor modulation). Indication/context: treatment of agitation associated with dementia due to Alzheimer\u2019s disease (studies and FDA approval for this indication). These facts are supported by the FDA approval announcement and prescribing information. \ue200cite\ue202turn0search0\ue202turn0search3\ue201",
        "Reflect: Classification check \u2014 CADRO category D) Neurotransmitter Receptors best fits because the mechanism is direct neurotransmitter receptor modulation (dopamine and serotonin receptors) and the trial aims to treat a neuropsychiatric symptom (agitation). This is not a disease\u2011modifying approach targeting amyloid, tau, inflammation, proteostasis, vasculature, or other CADRO categories, nor is it a diagnostic/non\u2011therapeutic study. Therefore D) is the appropriate single category (not R) Multi\u2011target). \ue200cite\ue202turn0search0\ue202turn0search5\ue201",
        "Web sources used (key search results): FDA press announcement \u2014 \"FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer\u2019s Disease\" (May 11, 2023). \ue200cite\ue202turn0search0\ue201",
        "EMPR / news summary describing mechanism and phase 3 trials for brexpiprazole. \ue200cite\ue202turn0search1\ue201",
        "Rexulti (brexpiprazole) prescribing information / label (summary of clinical trials and dosing). \ue200cite\ue202turn0search3\ue201",
        "Otsuka/Lundbeck press release on FDA approval for agitation in Alzheimer\u2019s disease. \ue200cite\ue202turn0search4\ue201",
        "REXULTI HCP product site (indications and safety information). \ue200cite\ue202turn0search5\ue201"
    ]
}